Navigation Links
Pharmasset to Present at Goldman Sachs and Needham Healthcare Conferences
Date:6/2/2009

nt of oral therapeutics for the treatment of hepatitis C virus (HCV) and, secondarily, on the development of Racivir(R) for the treatment of human immunodeficiency virus (HIV). Our research and development efforts focus on nucleos(t)ide analogs, a class of compounds which act to inhibit the enzymes required for viral replication. We currently have three clinical-stage product candidates: R7128, a nucleoside analog for chronic HCV infections, has initiated a Phase 2b clinical trial in combination with Pegasys plus Copegus through a strategic collaboration with Roche; PSI-7851, an unpartnered, next generation HCV nucleotide analog, which recently began Phase 1 clinical studies and Racivir, for the treatment of HIV that has completed a Phase 2 clinical trial.

Pegasys(R) and Copegus(R) are registered trademarks of Roche.

Forward-Looking Statements

Pharmasset "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding our business that are not historical facts are "forward-looking statements" that involve risks and uncertainties, including without limitation, the risk that adverse events could cause the cessation or delay of any of the ongoing or planned clinical trials and/or our development of our product candidates, the risk that the results of previously conducted studies involving our product candidates will not be repeated or observed in ongoing or future studies involving our product candidates, the risk that our collaboration with Roche will not continue or will not be successful and the risk that any one or more of our product candidates will not be successfully developed and commercialized. For a discussion of these risks and uncertainties, any of which could cause our actual results to differ from those contained in the forward-looking statements, see the section of our Annual Report on Form 10-K for the fiscal year ended September 30
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C
2. Pharmasset Voluntarily Halts Clinical Studies with Clevudine in Hepatitis B Infected Patients
3. Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)
4. Pharmasset Reports Fiscal Year End 2008 Financial Results
5. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
6. Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications
7. Pharmasset to Present at the UBS Global Life Sciences Conference on Wednesday, September 24th
8. Pharmasset Reports Financial Results for Quarter Ended June 30, 2008
9. Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
10. Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS)
11. Pharmasset Receives Notice of Allowance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... , May 6, 2015 CVS Health (NYSE: CVS ... Baltimore locations that sustained heavy fire damage during ... in Baltimore over the past week or ... is ahead," said CVS Health President and CEO Larry Merlo ... path to better health. There is no better way that we ...
(Date:5/6/2015)... , May 06, 2015 Research and ... the addition of the "Cannulas Market by ... Injector, Infusion, Venous, Microcannula), Material (Plastic, Metal) & ... Forecast to 2020" report to their offering. ... to grow at a CAGR of 5.6% from ...
(Date:5/6/2015)... , May 6, 2015  Rigrodsky & Long, P.A.: ... Pharmaceuticals, Inc. (NASDAQ GM: AERI )? , Did you ... inclusive? , Did you lose money in your investment in ... rights? Rigrodsky & Long, P.A. , ... , announces that a complaint has been filed in the United ...
Breaking Medicine Technology:CVS Health Announces it Will Rebuild Baltimore CVS/pharmacy Locations 2Global Cannulas Market 2015 - Forecasts to 2020 with Medtronic, Edward Lifesciences, Terumo, Sorin & Maquet Holding B.V. & Co. Dominating 2Global Cannulas Market 2015 - Forecasts to 2020 with Medtronic, Edward Lifesciences, Terumo, Sorin & Maquet Holding B.V. & Co. Dominating 3SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. 2SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. 3
... , NORCROSS, Ga., Nov. 23 Immucor, Inc. (Nasdaq: ... to the blood transfusion industry, today announced that access to ... Conference in New York, NY will be available via a ... scheduled for Tuesday, December 1, 2009, at 12:30 p.m. Eastern ...
... RICHMOND, Calif., Nov. 23 Transcept Pharmaceuticals, Inc. (Nasdaq: ... with the U.S. Food and Drug Administration (FDA) on January ... New Drug Application (NDA) for Intermezzo ® ... Letter, received by Transcept on October 28, 2009, indicated that ...
Cached Medicine Technology:Transcept Pharmaceuticals Scheduled to Meet With FDA to Discuss Intermezzo(R) Complete Response Letter 2
(Date:5/6/2015)... (PRWEB) May 06, 2015 The Beryl ... 1 of Patient Experience Journal (PXJ), an international, ... practices around understanding and improving patient experience. The second ... patient experience conversation globally, helps align the voices engaged ... , Published in association with The Beryl Institute, ...
(Date:5/6/2015)... “ SideChef ” was featured on NewsWatch as ... latest and coolest applications on the market for iOS, Android, and ... the app review and shared with viewers how this application walks ... to be a good navigator people had to know how to ... is a master navigator. Well what if people could “GPS” their ...
(Date:5/6/2015)... 06, 2015 Inversion Studios, a ... yoga and Pilates classes, provides personalized individual instruction ... starting with its new Pilates Ring magic circle. ... becoming leaner, stronger, more centered and graceful, Inversion ... fresh venue to healthy fitness through yoga and ...
(Date:5/6/2015)... 2015 Vancouver Chiropractic Clinic, Backs ... new blog containing the Canadian Physical Activity and ... Society for Exercise Physiology (CSEP). Since the CSEP ... and fitness research and personal training in Canada, ... highly beneficial and a rich resource for many ...
(Date:5/6/2015)... Systems, (“Anitoa”), a Palo Alto startup established in ... demonstrated a handheld real time quantitative-polymerase-chain-reaction system (qPCR) using ... is shown to be capable of detecting several types ... and E. Coli. This qPCR system has achieved detection ... orders of magnitude dynamic range. A key component ...
Breaking Medicine News(10 mins):Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:An Application to Guide Users through Recipes Was Featured on NewsWatch Television 2Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 2Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 3Health News:Vancouver Chiropractor Shares Canadian Physical Activity and Sedentary Behavior Guidelines by CSEP in New Blog 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 3
... first time have induced robust regeneration of nerve connections ... the potential for new therapeutic approaches to paralysis and ... rodents, the UC Irvine, UC San Diego and Harvard ... developmental clock in a molecular pathway critical for the ...
... HealthDay Reporter , FRIDAY, Aug. 6 (HealthDay ... endocrinologist and researcher of what they claim is the ... womb in a dispute that has drawn in leading ... experimental prenatal treatment of female fetuses for a condition ...
... Goodwin HealthDay Reporter , FRIDAY, Aug. 6 (HealthDay ... himself, thinks he,s superior to everyone and who tends to ... may very well have narcissistic personality disorder, a condition marked ... of empathy for others. And new research suggests the ...
... By Amanda Gardner HealthDay Reporter , ... most widely prescribed drugs in the United States may ... errors in diagnoses, a new study finds. ... elevated PSA (prostate-specific antigen)level, but new research shows that ...
... Researchers at UCLA,s Jonsson Comprehensive Cancer Center and ... and Laboratory Medicine have uncovered a role for ... the mitochondria, the energy-producing "power plant" of the ... into mitochondria is essential for the replication, transcription ...
... a significantly higher survival rate than either external-beam radiation or ... at UCSF. The differences among therapies were more prominent ... say, that in many cases surgery should play a greater ... is likely to recur or spread. The ...
Cached Medicine News:Health News:In breakthrough, nerve connections are regenerated after spinal cord injury 2Health News:Ethicists Charge Doctor With Trying to Prevent Homosexuality in the Womb 2Health News:Ethicists Charge Doctor With Trying to Prevent Homosexuality in the Womb 3Health News:Ethicists Charge Doctor With Trying to Prevent Homosexuality in the Womb 4Health News:Narcissistic Men Typically Direct Their Rage at Straight Women 2Health News:Narcissistic Men Typically Direct Their Rage at Straight Women 3Health News:Statins, Painkillers May Upset PSA Test Results 2Health News:Statins, Painkillers May Upset PSA Test Results 3Health News:UCLA researchers discover protein that shuttles RNA into cell mitochondria 2Health News:UCLA researchers discover protein that shuttles RNA into cell mitochondria 3Health News:Surgery better than radiation, hormone treatments for some prostate cancer, study shows 2Health News:Surgery better than radiation, hormone treatments for some prostate cancer, study shows 3
... saw to remove a cast from an arm ... Occasionally patients are cut or burned by the ... healthcare professionals to remove any cast with confidence. ... against cuts and burns from the cast saw ...
... bypass grafting or creation of a vascular ... tunnel is of the utmost importance in ... answer for those seeking a high-precision tunneling ... the risk of twisting or kinking for ...
... GORE-TEX Stretch Vascular Grafts have met ... vascular procedures. Recognized for exceptional performance ... endorsement of renowned surgeons worldwide. These ... and the spread of infection, and ...
... GORE-TEX Stretch Vascular Grafts have ... demanding vascular procedures. Recognized for exceptional ... the endorsement of renowned surgeons worldwide. ... dilatation and the spread of infection, ...
Medicine Products: